Abstract

A mixed-methods evaluation of an Irish remote model of opioid substitution treatment

Part of Special Series: WONCA World Rural Health Conference Abstracts 2022go to url

AUTHORS

name here
Des Crowley
1 MSc, MB, MICGP, PhD, Professor *

name here
Claire Collins
2 PhD, Chief Operating Officer ORCID logo

name here
Walter Cullen
3 Professor of General Practice

name here
Kieran Harkin
4 General Practitioner

name here
Robyn Homeniuk
5 Research Officer

name here
Ide Delargy
6 Director of Addiction Management in Primary Care , ICGP

CORRESPONDENCE

*Professor Des Crowley

AFFILIATIONS

1, 3 School Of Medicine, University College Dublin, Dublin, Ireland; and Irish College of General Practitioners, Dublin, Ireland

2, 4, 5, 6 Irish College of General Practitioners, Dublin, Ireland

PUBLISHED

10 January 2023 Volume 23 Issue 1

HISTORY

RECEIVED: 20 September 2022

ACCEPTED: 20 September 2022

CITATION

Crowley D, Collins C, Cullen W, Harkin K, Homeniuk R, Delargy I.  A mixed-methods evaluation of an Irish remote model of opioid substitution treatment. Rural and Remote Health 2023; 23: 8136. https://doi.org/10.22605/RRH8136

AUTHOR CONTRIBUTIONSgo to url

This work is licensed under a Creative Commons Attribution 4.0 International Licence

go to urlCited by

no pdf available, use your browser's print function to create one


abstract:

Introduction: Providing health care to rural communities is a challenge, particular for marginalised groups like people who use drugs. The ongoing COVID-19 pandemic further increases these challenges. The use of remote models of care, including telemedicine, help to mitigate the impact of COVID-19 and provide new opportunities to engage existing and new patients in treatment. It is recognised that people who used opioids have increased health needs and struggle to engage in health care compared to the general population. Opioid substitution treatment (OST) is effective at reducing these health inequalities but coverage is often inadequate. To increase access to OST during the pandemic, a national remote model of OST was developed in Ireland. An evaluation is being conducted 18 months after commencement to evaluate its effectiveness at engaging people in OST, its impact on their drug use, general health and quality of life. The evaluation also aims to describe the experiences of both services providers and users and report aspects that can be modified and improved.

Methods: A mixed-methods evaluation is being conducted. It consists of a chart review that collects demographic data (age, sex, family details and education and employment status). It also includes the collection and analysis of data on engagement in treatment, changes in drug use and general health. A series of one-to-one interviews are being conducted (service providers (n=12) and service users (n=10).Thematic analysis of the interview narratives will be conducted using NVivo 11.

Results and Discussion: The results will be ready in 2022.

You might also be interested in:

2021 - Pilot program integrating outpatient opioid treatment within a rural primary care setting

2021 - Tuberculosis in the Torres Strait: the lady doth test too much

2013 - Using Portable Health Information Kiosk to assess chronic disease burden in remote settings

This PDF has been produced for your convenience. Always refer to the live site https://www.rrh.org.au/journal/article/8136 for the Version of Record.